Healthcare’s Once-in-a-Generation Disruption

The cost of healthcare in the United States continues to rise and the availability continues to decline. Healthcare spending accounts for 18% of U.S. GDP, and the costs in the U.S. are the highest in the world, increasing 130% in just the last decade. With this complexity comes an opportunity for entrepreneurs, innovators, and investors. iSelect is focused on finding technologies and innovations that reduce costs, increase accessibility, and improve quality of care.

Our Companies | Our Network | Join Our Network | News

iSelect Portfolio Companies

iSelect focuses on early-stage healthcare companies that are poised to help push the next healthcare revolution forward. We deliberately invest in companies that can make a positive impact on our society, as well as on the bottom line.

Neuros Medical, Inc.

Neuros Medical, a medical device company, develops an electrical nerve block to treat chronic pain for conditions including neuroma/residual limb pain and chronic post-surgical pain. Learn more…

Company Website

Cocoon Biotech, Inc.

Fibroin is an insoluble protein that is responsible for silk’s structure and tensile strength. Additional physical properties include tunable viscosity, anti-inflammatory, and wound healing attributes. Cocoon’s fibroin is expected to yield substantial improvements in use-cases such as bio-preservatives, drug or small/molecule delivery, natural lubricants, and hydrogels across numerous industries including human and animal health, agriculture, and consumer products. Learn more…

Company Website

Nix, Inc.

Nix is developing a wearable, single-use patch that monitors hydration in real-time, without the need for a power-source or companion device/app. Learn more…

Company Website

MOBILion Systems

MOBILion Systems Inc. has developed ion mobility technology that can separate and identify previously undetectable, clinically significant molecules within minutes, enabling far more accurate disease diagnosis, biomarker discovery, drug discovery, and clinical trial design among other potential applications. Learn more…

Company Website

Shield Bio

Shield Bio is enabling 3rd generation sequencing to more rapidly and cost effectively diagnose and treat infectious disease while fighting antimicrobial resistance. Learn more…

Company Website

Molecular Assemblies

Molecular Assemblies is developing an enzymatic DNA synthesis platform technology, enabling new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, data storage, nanotechnology and more. Molecular Assemblies’ novel enzymatic DNA synthesis platform has the potential to fundamentally transform how we write genetic building blocks with applications across food, healthcare, energy, and beyond. Learn more…

Company Website

Healionics, Inc.

Healionics, Inc. has developed a novel bio-material called STAR, that features strong anti-infective properties and significant reduction in the formation of scar tissue around implanted medical devices coated with the material. Learn more…

Company Website

Holobiome, Inc.

Holobiome is developing a platform for microbiome-based therapeutics to treat diseases of the central and enteric nervous systems.  Learn more…

Company Website

SciBac, Inc.

SciBac is developing a platform technology called MERGE that enables the Company to efficiently combine desired traits of two microbes into one stable hybrid organism through lab-induced directed evolution. Learn more…

Company Website

GeneMatters, LLC

GeneMatters is a digital health platform that provides scalable, on-demand genetic counseling to meet the rapidly growing demand for genetic services. Learn more…

Company Website

Flywheel Exchange, LLC

Flywheel offers a SaaS platform that provides cloud-scale data management and computational analysis. Learn more…

Company Website

Cofactor Genomics, Inc.

Cofactor Genomics uses proprietary RNA sequencing (“RNA-Seq”) technology and machine learning algorithms to diagnose disease. Learn more…

Company Website

Entac Medical, Inc.

Entac Medical is developing noninvasive devices for predictive and diagnostic medicine based on a novel, patented, platform technology, Previs Audio Spectral Analysis. Their first product is used to predict post operative ileus after GI surgeries. Learn more…

Company Website

Indalo Therapeutics

Indalo Therapeutics is developing novel small-molecule therapeutics to differentially treat and prevent the rapidly growing class of fibrotic diseases affecting millions globally. Learn more…

Company Website

CareSignal

Epharmix is a healthcare software company substantially reducing the cost of care for chronic diseases using text messaging. Learn more…

Company Website

Gila Therapeutics, Inc.

Gila Therapeutics is developing a treatment for obesity using naturally occurring hormones known to induce satiety, leading to weight loss. Learn more…

Company Website

Euclises Pharmaceuticals, Inc.

Euclises Pharmaceuticals is developing novel enzyme (COX-2) inhibitors designed to increase the effectiveness of chemotherapy safely Learn more…

Company Website

Immunophotonics, Inc.

Immunophotonics has developed a minimally invasive therapeutic cancer vaccine for the treatment of metastatic solid tumors. Learn more…

Company Website

Meet Our Selection Committee

Our Healthcare Selection Committee consists of industry and subject matter experts who help guide iSelect’s investment decisions. With firsthand experience and a true pulse on the industry, we consider these individuals key to our success in finding and investing in healthcare innovation.

Tiffany Osborn

Read full bio >

Ruchir Sehra, M

Read full bio >

Surekha Trivedi

Read full bio >

Jill Davies is

Read full bio >

Vice President

Read full bio >

Jin-Moo Lee, MD

Read full bio >

Emily Fassi is

Read full bio >

Dr. David Messi

Read full bio >

Dr. Bruce Germa

Read full bio >

Jean Roberson

Jean Roberson i

Read full bio >

A regulatory pr

Read full bio >

Andrew Daniels

Andy Daniels is

Read full bio >

Dr. Paul D. Oli

Read full bio >

Bobby Sandage

Bobby Sandage i

Read full bio >

Lila Solnica-Kr

Read full bio >

Gian Cavallini

Read full bio >

Don Imholz

Mr. Don Imholz

Read full bio >

Michael Beat

Presently leadi

Read full bio >

Mr. Beuttenmull

Read full bio >

Professor of In

Read full bio >

Dr. John Talley

Read full bio >

Bryce Rutter

Dr. Rutter is f

Read full bio >

Mark has served

Read full bio >

Dr. Panagos is

Read full bio >

Before joining

Read full bio >

Dr. Raghavan br

Read full bio >

Edwards was emp

Read full bio >

Michael Nichols

Michael Nichols

Read full bio >

David Christenson

David Christens

Read full bio >

Professor of Me

Read full bio >

Renaldo Cataldo

An accomplished

Read full bio >

Join Our Healthcare Innovation Network

Join the thousands of entrepreneurs, investors, and industry professionals driving the future of healthcare.

Resources and News

Are We Really Ready for Genetic Testing?

Are We Really Ready for Genetic Testing?

There’s a lot we still don’t know about the power of genetic testing. For one thing, it’s becoming more powerful than ever expected. Already, patients can get gene-based information about their cancer risk, for instance, as well as details about genetic disorders that might impact their children, autism diagnoses, and more.

read more
Who Has Your DNA? Why Data Privacy Is the Next Battleground in Consumer Genetics

Who Has Your DNA? Why Data Privacy Is the Next Battleground in Consumer Genetics

Genetics is changing the world as we know it, and not only in the realm of healthcare and medical science. Whether it’s 23andMe delivering specific details about our ancestry, genetic science being used to united people who have been switched at birth, or even DNA information being used to catch the Golden State Killer, there is much that genomics can now accomplish.

read more
Dehydration Nation: Preventing One of the Most Common Health Risks in Real-Time

Dehydration Nation: Preventing One of the Most Common Health Risks in Real-Time

Up to three-fourths of Americans are chronically dehydrated, and the condition can be far more debilitating than it might seem. Mild dehydration — literally, not drinking enough water on a day-to-day basis — can impair cognitive performance by up to 20%, affecting reaction time, mental accuracy and memory. More severe cases, however, can result can result in seizures, brain damage, shock, and death.

read more
RNA Is Becoming the New DNA, Opening New Doors in Medicine

RNA Is Becoming the New DNA, Opening New Doors in Medicine

If a person’s DNA is the roadmap of their lifetime health, their RNA is more of a real-time barometer, recording what happens in their body on a minute-by-minute basis. Our DNA stores and transfers genetic information, but remains little changed throughout our lives. At best, it can tell us about the probability we will someday develop various diseases — whether or not we will get cancer, for instance, or be susceptible to diabetes or heart disease — but it  can’t tell us much about our current health.

read more
What iSelect Is Looking For in the Companies It Invests In

What iSelect Is Looking For in the Companies It Invests In

So people ask me what the optimal, or perfect, iSelect investment opportunity looks like. And there's a scientific, or a finance type of answer that I can give you that we're looking for a company that has an opportunity to have a 10 times return to our investor, or...

read more
Gila Therapeutics Completes Phase I Clinical Trial

Gila Therapeutics Completes Phase I Clinical Trial

Obesity drug developer, Gila Therapeutics, recently took a big step toward FDA approval for its new weight control treatment, completing its Phase I clinical trial in August. Gila is developing a novel intra-oral delivery of PYY, a well-known satiety hormone, to help...

read more
Who Has Your DNA? Why Data Privacy Is the Next Battleground in Consumer Genetics

DNA, RNA and the Coming Reality of Personalized Medicine

Medicine has always been a science of averages. Most people in the population tend to suffer from most of the same diseases, and most of those diseases respond to most of the same treatments. If one therapy doesn’t work, doctors always have other drugs and other...

read more